Mobile Health Exercise Program for Cancer Survivors

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: The University of Tennessee, Knoxville

No Placebo Group

Trial Summary

What is the purpose of this trial?

Participation in regular physical activity is vital to a healthy lifestyle. Research has shown that regular participation in physical activity among cancer survivors is not only able to improve health outcomes, but is also related to their quality of life. As we live in an age of technology, health wearables and smartphone apps might be one novel manner by which to help cancer survivors increase physical activity as well as improve health outcomes. Yet, the effectiveness of wearable and app as a tool for health promotion among cancer survivors is largely unstudied. The purpose of this study is to evaluate the effectiveness of a personalized m-health intervention via fitness wearable (Fitbit Inspire 3) exercise app (sFitRx) on physical activity, weight, quality of life, individual beliefs, and emotions among cancer survivors.

Eligibility Criteria

This trial is for cancer survivors leading a sedentary lifestyle who are interested in improving their physical activity and health outcomes. Participants should be comfortable using mobile health technology like fitness trackers.

Inclusion Criteria

I was diagnosed with cancer at an early to mid-stage.

Participant possess basic English communication capability

Participant do not participate in other health promotion programs

See 7 more

Exclusion Criteria

My cancer has spread to distant parts of my body.

My cancer is stage 4.

Participant is already engaging in ≥75 min/week of vigorous-intensity PA, ≥150 min/week of moderate-intensity PA, or an equivalent combination of both over the last 3 months

See 7 more

Treatment Details

Interventions

mHealth/sFitRx (Behavioural Intervention)

Trial OverviewThe study tests if a personalized exercise program delivered through a mobile app (sFitRx) and monitored with a Fitbit Inspire 3 can increase physical activity and improve weight, quality of life, beliefs, and emotions among cancer survivors.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Experimental GroupExperimental Treatment1 Intervention

Experimental Group participants would receive access to a study-developed mHealth application, sFitRx, that delivers personalized PA programming as well as be provided with a fitness tracker to monitor their habitual PA levels.

Group II: Comparison GroupActive Control1 Intervention

Comparison Group participants would receive the fitness tracker only.